Management is Conservative on 2013 Sales I believe $130-140 million on the high end
Sales will continue to grow at a 30% clip each quarter. Hospitals in this country are starting to warm up to the fact that they can give less opiates with Ofirmev. 50% of the opiates used in the world ( medicianl not illegal opiates) are used in the the U.S. The medical profession uses way too much opiates in their practice.
This was my forecast prior to the VA adding Ofirmev to its National Formulary. I believe over the next 3 quarters the VA will add 10 million in sales. That puts yearly sales at around $140-145 million high end. Cadence will be a high flyer this year if it doesn't get bought out in the high teens low 20's